相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae
Yuriz Bakhtiar et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response
Stine Lyngvi Fougner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
New directions in pharmacological treatment of acromegaly
Jens Bollerslev et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Guidelines for Acromegaly Management: An Update
S. Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Clinicopathological features of growth hormone-producing pituitary adenomas: Difference among various types defined by cytokeratin distribution pattern including a transitional form
Abdulkader Obari et al.
ENDOCRINE PATHOLOGY (2008)
Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR
Giselle F. Taboada et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Low levels of Raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment
Stine Lyngvi Fougner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Selective loss of somatostatin receptor 2 in octreotide-resistant growth hormone-secreting adenomas
Ursula Ploeckinger et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The clinical response to somatostatin analogues in acromegaly correlates to the somatostatin receptor subtype 2a protein expression of the adenoma
Stine L. Fougner et al.
CLINICAL ENDOCRINOLOGY (2008)
A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors
Sylvia L. Asa et al.
CANCER RESEARCH (2007)
Pathology of acromegaly
Eva Horvath et al.
NEUROENDOCRINOLOGY (2006)
Does the prevalence of gsp mutations in GH-secreting pituitary adenomas differ geographically or racially? Prevalence of gsp mutations in Japanese patients revisited
J Yasufuku-Takano et al.
CLINICAL ENDOCRINOLOGY (2006)
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly
S Bhayana et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
GSPα mutations in Mexican patients with acromegaly:: potential impact on long term prognosis
V Mendoza et al.
GROWTH HORMONE & IGF RESEARCH (2005)
Somatostatin (SRIF) receptor subtype 2 and 5 gene expression in growth hormone-secreting pituitary adenomas: The relationship with endogenous SRIF activity and response to octreotide
CY Park et al.
ENDOCRINE JOURNAL (2004)
Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly
J Ayuk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas
H Nishioka et al.
CLINICAL ENDOCRINOLOGY (2003)
Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies
B Xu et al.
ENDOCRINE PATHOLOGY (2002)
Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas:: analysis of gene sequence and mRNA expression
S Corbetta et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)
Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas
HJ Kim et al.
JOURNAL OF ENDOCRINOLOGY (2001)
分享论文
